Taiwanese Pharmaceuticals & Biotech Upcoming Dividends

PharmaEngine

Market Cap: NT$8.6b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

Bora Pharmaceuticals

Market Cap: NT$58.2b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Standard Chemical & Pharmaceutical

Market Cap: NT$10.2b

Manufactures and sells pharmaceutical products in Taiwan and internationally.

Chi Sheng Pharma & Biotech

Market Cap: NT$1.7b

Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.

Sinphar PharmaceuticalLtd

Market Cap: NT$6.2b

Engages in the production, processing, selling, and trading of various medicines, chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

Formosa Laboratories

Market Cap: NT$5.9b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

Maxigen Biotech

Market Cap: NT$3.6b

Researches, develops, produces, and sells implantable medical devices in Taiwan, America, Europe, rest of Asia, and internationally.

RBC Bioscience

Market Cap: NT$290.5m

Manufactures and sells reagents and devices for life science and molecular diagnosis.

BioLASCO Taiwan

Market Cap: NT$751.7m

Operates an animal breeding center to produce specific pathogen-free laboratory animals in Taiwan and internationally.